InsidersTradesSigma
Track the Panacea Biotec Limited share price and the full insider trade history of the company, a publicly traded company based in India. Shares are quoted on the IN market, under the oversight of SEBI (PIT + SAST). Operating in the Health Care sector, Panacea Biotec Limited has logged 43 reports. Market capitalisation: €25.8bn. The latest transaction was disclosed on 1 October 2025 (Purchase). Among the most active insiders: Sandeep Jain. The full history is free.
43
Insider Decl.
n/a
Thresholds
€27,091
6 ops.
Buy Volume
€2m
37 ops.
Sell Volume
18Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 18,091 of 29,063 companies
44.4
score / 100
Value32
Quality57
FCF yld-1.4%
Earn yld-0.2%
EV/EBITDA·
ROE·
Gross mgn56%
Net mgn-0.8%
Debt/EBITDA0.7x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 1 October 2025
Declarations43 total
3,000 shares@ ₹406.7777100.0% of flowEquity SharesSEBI:d2531a22a08c1452f891689e506a46a681d5ddd6
5,000 shares@ ₹409.0651.1% of flowEquity SharesSEBI:3bd88e123b405914c61459d48f160a4df2c4f9f3
10,000 shares@ ₹425.04432.2% of flowEquity SharesSEBI:fcb9ee1e3f6c8bb02a5d696cebb990894baccd4e
3,000 shares@ ₹454.90100.0% of flowEquity SharesSEBI:7b73df1387e62a9ee631f04d0a00273a0acd5d5e
5,000 shares@ ₹426.23161.1% of flowEquity SharesSEBI:7dfd938bfc564e9762a82015f4b85ffa893e285b
10,000 shares@ ₹439.55172.3% of flowEquity SharesSEBI:ffc94f4fe7d66abafaf51be941fbbb9d7a9e08ce
5,000 shares@ ₹450.88661.2% of flowEquity SharesSEBI:03c4b81f55cad645b2568e34b6ddcb8fc36762aa
5,700 shares@ ₹455.321.3% of flowEquity SharesSEBI:9f64803e0e5d629864138158e6175a82daabab8d
5,500 shares@ ₹485.0881.4% of flowEquity SharesSEBI:d2e35847162b19a70818e32a6ebea29c46aa7fc5
11,000 shares@ ₹470.77542.7% of flowEquity SharesSEBI:db4355e75b0b8085bd162940d5e17b866b9cc836
5,500 shares@ ₹464.15271.3% of flowEquity SharesSEBI:37458fdfbb2f60ce1720c437cd9f82e58c010aac
10,000 shares@ ₹448.90312.3% of flowEquity SharesSEBI:2c56d4319fd54e803bf3a7c96787b47441485f03
10,000 shares@ ₹456.81632.3% of flowEquity SharesSEBI:bfef4207ab115223feee5b6444dd189fb2314b61
10,000 shares@ ₹424.15452.2% of flowEquity SharesSEBI:eda216e282e3a715d9c192832b8dd6ee63d9a2a7
12,500 shares@ ₹418.0732.7% of flowEquity SharesSEBI:c370bea6d2422d5dafe15530167e6a7f674fddb1
8,655 shares@ ₹418.621.9% of flowEquity SharesSEBI:934f51b0bb18c36e14be084e0244bbaa1ef0bb82
20,112 shares@ ₹406.40664.2% of flowEquity SharesSEBI:c648d962703511f41e30023cd3cb23ed0592dd7e
54,000 shares@ ₹384.067110.6% of flowEquity SharesSEBI:4ec67933dc907c3f424ba52fc9157a789e5e009c
70,275 shares@ ₹294.735810.1% of flowEquity SharesSEBI:fe043bbc09cee2e2371e2528c07ab1dcaaaa8088
2,822 shares@ ₹289.46140.4% of flowEquity SharesSEBI:b6c326c1ead5078380e702a3700629768bda4b93
10,420 shares@ ₹308.85241.6% of flowEquity SharesSEBI:d01aec5ff49ca158445fb97bac9d1e7d79c2434a
17,500 shares@ ₹349.00663.0% of flowEquity SharesSEBI:0b404d7973a9cea176029ad58cdaa923cea713e3
34,005 shares@ ₹321.07425.4% of flowEquity SharesSEBI:d293c61eb44291cf6451d6ae5ec91a0d84c2d973
33,469 shares@ ₹281.51494.7% of flowEquity SharesSEBI:8737728d3af71a468ec71fb5a054658b25ee3251
123,865 shares@ ₹266.799216.2% of flowEquity SharesSEBI:dcca48c60e9141c2f5112d44cbf2119ebe6b04f7
25 of 43 declarations
关于 Panacea Biotec Limited
Panacea Biotec Limited 是一家专注于医疗保健和制药领域的公司，提供创新的生物制药解决方案。该公司在 XBOM 上市。